Asthma drug shows Real-World relief for severe cases in taiwan

NCT ID NCT05734339

First seen Apr 25, 2026 · Last updated May 14, 2026 · Updated 3 times

Summary

This study followed 43 adults in Taiwan with severe uncontrolled asthma who were prescribed benralizumab. Researchers tracked changes in asthma control using a standard questionnaire over time. The goal was to see how well the drug works in everyday life, not just in a lab.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Research Site

    Changhua, Taiwan

  • Research Site

    Kaohsiung City, Taiwan

  • Research Site

    New Taipei City, Taiwan

  • Research Site

    Tainan, Taiwan

  • Research Site

    Taipei, Taiwan

  • Research Site

    Taoyuan City, Taiwan

Conditions

Explore the condition pages connected to this study.